Curcumin attenuates the expression and secretion of RANTES after spinal cord injury in vivo and lipopolysaccharide-induced astrocyte reactivation in vitro.

Curcumin has been proposed for treatment of various neuroinflammatory and neurodegenerative conditions, including post-traumatic inflammation during acute spinal cord injury (SCI). In this study, we examined whether curcumin anti-inflammation involves regulation of astrocyte reactivation, with special focus on the injury-induced RANTES (regulated on expression normal T-cell expressed and secreted) from astrocytes in acute SCI. Male Sprague-Dawley (SD) rats were subjected to impact injury of the spinal cord followed by treatment with curcumin (40 mg/kg i.p.). RANTES and inducible nitric oxide synthase expression as well as RANTES-positive astrocytes were all induced by injury accompanied by the elevation of lipid peroxidation, and attenuated by the curcumin treatment. In primary cultured rat astrocytes challenged with lipopolysaccharide (LPS) to mimic astrocyte reactivation following SCI, LPS induces robust increase of RANTES expression and the effect was also reduced by 1 μM curcumin treatment. Furthermore, cortical neurons cultured with astrocyte conditioned medium (ACM) conditioned with both LPS and curcumin (LPS-curcumin/ACM), which characteristically exhibited decreased RANTES expression when compared with ACM from astrocytes treated with LPS alone (LPS/ACM), showed higher level of cell viability and lower level of cell death as assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity assay and lactate dehydrogenase release assay, respectively. Knockdown of RANTES expression by siRNA (siRANTES) shows reduced RANTES expression and release from LPS-reactivated astrocytes, and ACM obtained from this condition (LPS-siRANTES/ACM) becomes less cytotoxic as compared with the LPS-ACM. Therefore, curcumin reduction of robust RANTES production in reactivated astrocytes both in vitro and in vivo may contribute to its neuroprotection and potential application in SCI.

[1]  C. Chou,et al.  Glucocorticoid Protection of Oligodendrocytes against Excitotoxin Involving Hypoxia-Inducible Factor-1α in a Cell-Type-Specific Manner , 2010, The Journal of Neuroscience.

[2]  Yung-Hyun Choi,et al.  Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. , 2010, International immunopharmacology.

[3]  M. Tsai,et al.  CC-chemokine ligand 18/pulmonary activation-regulated chemokine expression in the CNS with special reference to traumatic brain injuries and neoplastic disorders , 2010, Neuroscience.

[4]  P. Grammas,et al.  RANTES upregulation in the Alzheimer's disease brain: A possible neuroprotective role , 2010, Neurobiology of Aging.

[5]  D. Dickson,et al.  Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes , 2008, The Journal of Neuroscience.

[6]  C. Chou,et al.  Neuronal activity enhances aryl hydrocarbon receptor‐mediated gene expression and dioxin neurotoxicity in cortical neurons , 2008, Journal of neurochemistry.

[7]  Serge Rossignol,et al.  Spinal Cord Injury: Time to Move? , 2007, The Journal of Neuroscience.

[8]  Y. Turkoz,et al.  Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury , 2007, Journal of Clinical Neuroscience.

[9]  R. Kowluru,et al.  Effects of curcumin on retinal oxidative stress and inflammation in diabetes , 2007, Nutrition & metabolism.

[10]  Claudia Röhl,et al.  The effect of activated microglia on astrogliosis parameters in astrocyte cultures , 2007, Brain Research.

[11]  H. Bramlett,et al.  Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. , 2007, Progress in brain research.

[12]  V. Menon,et al.  Antioxidant and anti-inflammatory properties of curcumin. , 2007, Advances in experimental medicine and biology.

[13]  Michael A Berman,et al.  RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. , 2006, Molecular cell.

[14]  J. Pease.  Tails of the unexpected – an atypical receptor for the chemokine RANTES/CCL5 expressed in brain , 2006, British journal of pharmacology.

[15]  R. Orlando,et al.  TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin. , 2006, Biochemical pharmacology.

[16]  F. Kuang,et al.  ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury. , 2006, Life sciences.

[17]  R. Macdonald,et al.  Neuroprotective mechanisms of curcumin against cerebral ischemia‐induced neuronal apoptosis and behavioral deficits , 2005, Journal of neuroscience research.

[18]  P. Popovich,et al.  Molecular Control of Physiological and Pathological T-Cell Recruitment after Mouse Spinal Cord Injury , 2005, The Journal of Neuroscience.

[19]  T. Santoro,et al.  Astrocyte production of the chemokine macrophage inflammatory protein-2 is inhibited by the spice principle curcumin at the level of gene transcription , 2005, Journal of Neuroinflammation.

[20]  S. Howng,et al.  Calpain Inhibitor Inhibits p35-p25-Cdk5 Activation, Decreases Tau Hyperphosphorylation, and Improves Neurological Function after Spinal Cord Hemisection in Rats , 2005, Journal of neuropathology and experimental neurology.

[21]  I. Verma,et al.  Nuclear factor (NF)-κB proteins: therapeutic targets* , 2004 .

[22]  T. Wynn.  Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.

[23]  J. Takeba,et al.  Delayed neuronal damage related to microglia proliferation after mild spinal cord compression injury , 2003, Neuroscience Research.

[24]  G. Tennekoon,et al.  Lysophosphatidic Acid Promotes Survival and Differentiation of Rat Schwann Cells* , 2003, The Journal of Biological Chemistry.

[25]  M. Dorf,et al.  RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes , 2002, Glia.

[26]  D. Basso,et al.  Pathological CNS Autoimmune Disease Triggered by Traumatic Spinal Cord Injury: Implications for Autoimmune Vaccine Therapy , 2002, The Journal of Neuroscience.

[27]  G. Stoll,et al.  Cytokines in CNS disorders: neurotoxicity versus neuroprotection. , 2000, Journal of neural transmission. Supplementum.

[28]  R. Maki,et al.  Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. , 1999, Trends in pharmacological sciences.

[29]  H. Müller,et al.  The CNS lesion scar: new vistas on an old regeneration barrier , 1998, Cell and Tissue Research.

[30]  M. Chan,et al.  In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. , 1998, Biochemical pharmacology.

[31]  M. Fehlings,et al.  Role of NMDA and Non-NMDA Ionotropic Glutamate Receptors in Traumatic Spinal Cord Axonal Injury , 1997, The Journal of Neuroscience.

[32]  K. Priyadarsini.  Free radical reactions of curcumin in membrane models. , 1997, Free radical biology & medicine.

[33]  Pauline M. Field,et al.  Regeneration of Cut Adult Axons Fails Even in the Presence of Continuous Aligned Glial Pathways , 1996, Experimental Neurology.

[34]  R. Ransohoff,et al.  Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. , 1996, Journal of immunology.

[35]  C. Brosnan,et al.  Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. , 1996, Journal of immunology.

[36]  K. Fukuzawa,et al.  Roles of nitric oxide in compression injury of rat spinal cord. , 1996, Free radical biology & medicine.

[37]  T. Schall,et al.  A human T cell-specific molecule is a member of a new gene family. , 1988, Journal of immunology.

[38]  M. Uchiyama,et al.  Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. , 1978, Analytical biochemistry.